Protocol Ledger

NCT07747103 · Phase III · RECRUITING

An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets.

Interventional Phase III clinical trial protocol NCT07747103 sponsored by Neuvosyn Laboratories in Endocrinology, Obesity, and Metabolic, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-06-30 Enrollment: 466 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07747103
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)466 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07747103
Protocol FieldVerified Registry Value
NCT IdentifierNCT07747103
Consolidated Lead SponsorNeuvosyn Laboratories
Therapeutic Condition CohortEndocrinology, Obesity, and Metabolic
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment466 participants (ESTIMATED)
Registered Start Date2026-06-30
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI